Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer

This study was performed to assess the efficacy and safety of docetaxel, cisplatin and fluorouracil combination in patients with unresectable locally advanced oesophageal squamous cell carcinoma. Treatment consisted of docetaxel 60 mg m(−2), cisplatin 75 mg m(−2) on day 1 and fluorouracil 750 mg m(−...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chiarion-Sileni, V, Corti, L, Ruol, A, Innocente, R, Boso, C, Del Bianco, P, Pigozzo, J, Mazzarotto, R, Tomassi, O, Ancona, E
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2007
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360020/
https://ncbi.nlm.nih.gov/pubmed/17245338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603585
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares